The invention relates to a pharmaceutical composition comprising a tetracyclononane derivative of the formula:
wherein R1, R2 and R3 are hydrogen atoms or alkyl radicals and A is CH2CH2 or CH-R4 in which R4- is a hydrogen atom or an alkyl, cyclohexyl, phenylalkyl or optionally-substituted phenyl radical, or a salt thereof. The majority of compounds of the formula II are novel and they are included within the scope of the invention, as are processes for their manufacture. Typical of the compounds disclosed is 8-(1-aminoethyl)tetracyclo-[4,3,0,02,4,03,7]nonane.
本发明涉及一种药物组合物,该组合物包含式中的四
环壬烷衍
生物:
其中R1、R2和R3为氢原子或烷基,A为CH2CH2或CH-R4,其中R4-为氢原子或烷基、环己基、苯基烷基或任选取代的苯基基,或其盐。大多数式 II 的化合物都是新颖的,它们包括在本发明的范围内,其制造工艺也包括在本发明的范围内。所公开的典型化合物是 8-(1-
氨基乙基)四环-[4,3,0,02,4,03,7]
壬烷。